From complex trial designs and cycle time pressures to the ongoing challenge of integrating diverse data sources, oncology studies continue to push the boundaries of scientific innovation and data-driven decision-making. 

Inspired by key themes from ASCO — where smarter trial design and the use of real-world data were emphasized — experts from MMS explore what makes these studies so different, and why that matters. They’ll share lessons learned from real-world experience across trial design, data management, data science, and biostatistics. Along the way, they’ll offer practical tips to help sponsors make better use of their data, avoid common pitfalls, and move more confidently through complex oncology programs. 

Join Aiden Flynn (SVP, Strategic Consulting), Doreen Van Huyssteen (Director, Data Management), and Amy McCorry (Senior Consultant, Data Scientist), moderated by Nimish Sidhpura (VP, North America Sales) for  a focused, multi-disciplinary conversation on the practical steps biotech and biopharma sponsors can take to design and deliver more effective oncology trials — with smarter use of data, clearer decisions, and better overall outcomes.  

Watch This Webinar To:  
  • Gain lessons learned from common data and design pitfalls — and how to avoid them 
  • Understand how thoughtful design and fit-for-purpose data strategies drive better decisions and reduce risk 
  • Explore innovative design approaches, including external controls, adaptive methodologies, and biomarker-driven strategies 
  • Discuss real-time data access and its impact on managing emerging data sources and complex protocols 
  • Learn how data science techniques — including simulation — are shaping trial strategy and delivery 
What You Will Learn:
  • How to proactively spot and solve common challenges in oncology trial design and data execution 
  • Ways to align design, data collection, and analytics from the outset 
  • Emerging trial design innovations and when to use them 
  • How to manage complex data streams in oncology 
Who will benefit from attending?
  • Chief Medical Officers 
  • Clinical Operations and Clinical Development professionals 
  • Program and Trial Leads 
  • Data Managers 
  • Biostatisticians 
  • Clinical Scientists 
  • Medical Directors 
  • Regulatory Affairs professionals 
  • Real-World Evidence (RWE) specialists 
  • Data Scientists 
FAQs

Who is this webinar for?
This webinar and panel discussion is designed for biotech and pharmaceutical leaders, clinical development professionals, biostatisticians, and clinical data scientists seeking actionable strategies to optimize oncology trials.

Will there be a recording available?
Yes, a recording will be provided to all registered attendees following the scheduled event.

Where can I get more information on the content presented?
To connect with the presenters, email info@mmsholdings.com and our team will connect you with the right person.

Meet our Speakers
Aiden Flynn
SVP, Strategic Consulting
Doreen Van Huyssteen
Director, Data Management
Amy McCorry
Senior Consultant, Data Scientist
Nimish Sidhpura
VP, North America Sales

Register Now

Suggested For You

webinar

April 30th, 2025

Advancing Clinical Development with Innovative Trial Design and Regulatory Strategies

webinar

March 25th, 2025

Overcoming NDA/BLA Submission Challenges: Practical Strategies for Success

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

webinar

September 12th, 2024

No Stone Unturned: Optimizing the Use of Expedited Pathways and Oncology Center of Excellence Programs to Optimize Drug Development in Oncology

webinar

July 11th, 2024

The Rising Burden of Pharmacovigilance (PV) Requirements in Early Drug Development

webinar

June 26th, 2024

A Psychedelic Shift: Assessing the Potential for Nonmedical Use in a Changing Regulatory Landscape

webinar

March 26th, 2024

Type II Drug Master Files for Early-Stage, Small Molecule, Drug Development: Regulatory Management, Quality Considerations, and eCTD Submission

webinar

January 18th, 2024

Best Practices for Data Visualization in Pharma, presented by MMS Holdings Data Science leaders

webinar

January 18th, 2024

The Wisdom Study: Revolutionizing Breast Cancer Screening, Detection & Prevention

webinar

January 18th, 2024

Evolving Your FSP Relationships to Achieve Maximum Return

webinar

January 18th, 2024

Avoiding Common Pitfalls in the IND & CTA Submission Process